about
Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.Combined deletion and DNA methylation result in silencing of FAM107A gene in laryngeal tumorsNarrowing the localization of the region breakpoint in most frequent Robertsonian translocationsThe negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal CarcinomaB-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib.Proteomic profiling identifies the inorganic pyrophosphatase (PPA1) protein as a potential biomarker of metastasis in laryngeal squamous cell carcinoma.Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma.Induction of expression of aryl hydrocarbon receptor-dependent genes in human HepaRG cell line modified by shRNA and treated with β-naphthoflavoneAssessment of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in benign and malignant salivary gland neoplasms.Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.Diversified expression of aryl hydrocarbon receptor dependent genes in human laryngeal squamous cell carcinoma cell lines treated with β-naphthoflavone.Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization.The prognostic significance of surface dipeptidylpeptidase IV (CD26) expression in B-cell chronic lymphocytic leukemia.Cytogenetic and flow cytometry evaluation of Richter syndrome reveals MYC, CDKN2A, IGH alterations with loss of CD52, CD62L and increase of CD71 antigen expression as the most frequent recurrent abnormalities.Transient presence of clonal chromosomal aberrations in Ph-negative cells in patients with chronic myeloid leukemia remaining in deep molecular response on tyrosine kinase inhibitor treatment.Autosomal recessive cone-rod dystrophy can be caused by mutations in the ATF6 gene.Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype - retrospective analysis of Polish Adult Leukemia Group (PALG).Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylationDIAPH2 alterations increase cellular motility and may contribute to the metastatic potential of laryngeal squamous cell carcinomaCharacterization and significance of the Philadelphia negative/BCR-ABL1 positive rearrangement or masked Philadelphia translocation in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single-center studyCopy number gains of the putative CRKL oncogene in laryngeal squamous cell carcinoma result in strong nuclear expression of the protein and influence cell proliferation and migrationExpression of Serpin Peptidase Inhibitor B2 (SERPINB2) is regulated by Aryl hydrocarbon receptor (AhR)
P50
Q33720509-064B0188-3D97-453C-B97F-DD507C8AC575Q33905652-AFD0A77D-46D2-49E0-A90F-B1586EC8D7CEQ34041881-5BB655F4-B981-4302-BC51-8200970CC396Q35596876-DED902B2-D76B-412E-B82A-2868AB5BD732Q35875417-6A9CEA96-74D5-4821-88B1-B71B36BD7AAEQ36726837-A2C0C1DA-49B0-45DF-A9C1-F9D558ABCC6EQ36924057-6596BDF9-107D-4331-924B-F8C1E80227EAQ37208190-6F5DE931-C902-42F3-908C-FCDF2B8C44BAQ37578440-515200F9-A092-40FD-911F-CFED103AE94CQ38377890-A2903108-29BC-495A-A61F-9AD622570FA8Q38710424-8544C116-5C96-46D7-B677-8A117F898FE8Q38956872-BC3959D9-6DBD-4E7E-B6DA-43A30174F14CQ39001461-6AB73CE7-A918-41AE-8C6B-1BF80A88C656Q39154930-16E3C7C1-6913-48A9-9206-45FF7C932184Q39633716-567C0256-E4BA-4D4F-AB02-2AD53737F283Q41686070-A5973D38-BEF1-4FE5-B5F0-C9BD45ACE7BAQ41703009-B072A353-E135-4204-AB48-834F1427A82DQ45933371-75FA1AD3-E2E2-4F6F-B13F-8688266AD24DQ51375505-0E442877-84E8-45DB-858E-DC4A557AD28FQ52953786-73F9C1EA-8B8B-42A4-989D-6E3EC105C27EQ88133287-BE972690-A86C-44DC-95D5-C5529A2A3CE6Q91820650-00B98E84-BAF8-4372-8FB7-F7156C3CFF55Q92468489-41779158-D6CE-4663-B6B9-D99C3100DDB4Q92491692-D020568F-5851-4118-90B5-617B101E960BQ92604948-BB9AA7C3-03A3-4888-B717-67B0B94B62C4
P50
description
researcher ORCID ID = 0000-0003-0437-5806
@en
name
Malgorzata Jarmuz-Szymczak
@ast
Malgorzata Jarmuz-Szymczak
@en
Malgorzata Jarmuz-Szymczak
@es
Malgorzata Jarmuz-Szymczak
@nl
Małgorzata Jarmuż-Szymczak
@ca
Małgorzata Jarmuż-Szymczak
@cs
Małgorzata Jarmuż-Szymczak
@gl
Małgorzata Jarmuż-Szymczak
@hr
Małgorzata Jarmuż-Szymczak
@hsb
Małgorzata Jarmuż-Szymczak
@it
type
label
Malgorzata Jarmuz-Szymczak
@ast
Malgorzata Jarmuz-Szymczak
@en
Malgorzata Jarmuz-Szymczak
@es
Malgorzata Jarmuz-Szymczak
@nl
Małgorzata Jarmuż-Szymczak
@ca
Małgorzata Jarmuż-Szymczak
@cs
Małgorzata Jarmuż-Szymczak
@gl
Małgorzata Jarmuż-Szymczak
@hr
Małgorzata Jarmuż-Szymczak
@hsb
Małgorzata Jarmuż-Szymczak
@it
prefLabel
Malgorzata Jarmuz-Szymczak
@ast
Malgorzata Jarmuz-Szymczak
@en
Malgorzata Jarmuz-Szymczak
@es
Malgorzata Jarmuz-Szymczak
@nl
Małgorzata Jarmuż-Szymczak
@ca
Małgorzata Jarmuż-Szymczak
@cs
Małgorzata Jarmuż-Szymczak
@gl
Małgorzata Jarmuż-Szymczak
@hr
Małgorzata Jarmuż-Szymczak
@hsb
Małgorzata Jarmuż-Szymczak
@it
P214
P1153
6602946403
P1412
P1559
Małgorzata Jarmuż-Szymczak
@pl
P21
P214
P27
P31
P3124
P496
0000-0003-0437-5806